| Detailed information |
|---|
| CancerLivER ID | 2240 |
| Biomarker | lncRNA-hPVT1 |
| Biomarker Name/Symbol (given in Publication) | lncRNA-hPVT1 |
| Biomolecule | LncRNA |
| Subject | Human |
| Degree of Validity | Patients with higher lncRNA-hPVT1 expression had a poor clinical prognosis; but not validated on independent dataset |
| Experimental Condition | HCC v/s Normal; associated with recurrence and survival in patients |
| Cancer type | Hepatocellular carcinoma |
| Regulation | Upregulated in HCC and higher hPVT1 expression levels in HCC tissues significantly correlated with markedly reduced recurrence-free survival |
| Level of significance | p < 0.001 |
| Source | Tissue |
| PMID | 25043274 |
| Type of Biomarker | Diagnostic and Prognostic |
| Pathway | NA |
| Cohort | 89 pairs of human HCC tissues and pair matched normal liver tissues |
| Sensitivity | NA |
| Specificity | NA |
| Accuracy | NA |
| AUC | NA |
| Disease | Human HCC |
| Year of Publication | 2014 |
| Clinical trial | NO |
| Clinical trial (NCT Number) | NA |